Skip to content
HowShorted

Alaunos Therapeutics, Inc. short interest in 2022

In 2022, Alaunos Therapeutics, Inc.'s disclosed short interest ran from 16.32% of shares outstanding on 14 Jan 2022 to 12.06% on 30 Dec 2022, a change of -4.26 percentage points. The year's high was 16.64% on 13 May 2022 and its low 12.06% on 30 Dec 2022, averaging 14.40% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.42 days on 15 Nov 2022. Full history: Alaunos Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Alaunos Therapeutics, Inc. in 2022

2022 in figures

Start of year
16.32% (14 Jan 2022)
End of year
12.06% (30 Dec 2022)
Change
-4.26 pp
High
16.64% (13 May 2022)
Low
12.06% (30 Dec 2022)
Average
14.40%
Highest days to cover
27.42 (15 Nov 2022)
SEC filings marked
8

Every report in 2022

Alaunos Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202216.32%17.93
14 Apr 202215.83%19.0310-K filed, results (8-K)
29 Apr 202215.65%13.16
13 May 202216.64%11.43
31 May 202216.63%20.1010-Q filed, results (8-K)
15 Jun 202216.31%6.16
30 Jun 202213.23%5.47
15 Jul 202213.36%15.73
29 Jul 202213.95%24.84
15 Aug 202213.43%14.4110-Q filed, results (8-K)
31 Aug 202213.44%9.46
15 Sep 202212.95%3.46
30 Sep 202213.45%4.32
14 Oct 202213.59%11.56
31 Oct 202214.88%26.02
15 Nov 202214.66%27.4210-Q filed, results (8-K)
30 Nov 202214.47%13.12
15 Dec 202212.81%18.16
30 Dec 202212.06%12.27

See also: Alaunos Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.